Bio-Reference Laboratories Inc  

(Public, NASDAQ:BRLI)   Watch this stock  
Find more results for BRLI
-0.30 (-0.85%)
Feb 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 34.82 - 35.40
52 week 24.19 - 35.57
Open 35.21
Vol / Avg. 170,415.00/235,890.00
Mkt cap 977.90M
P/E 20.82
Div/yield     -
EPS 1.68
Shares 27.75M
Beta 0.79
Inst. own 84%
Mar 5, 2015
Q1 2015 Bio-Reference Laboratories Inc Earnings Call - 10:30AM EST - Add to calendar
Mar 5, 2015
Q1 2015 Bio-Reference Laboratories Inc Earnings Release - 9:30AM EST - Add to calendar
Dec 18, 2014
Q4 2014 Bio-Reference Laboratories Inc Earnings Call - Webcast
Dec 18, 2014
Q4 2014 Bio-Reference Laboratories Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q4 (Oct '14) 2014
Net profit margin 8.03% 5.62%
Operating margin 13.53% 10.02%
EBITD margin - 13.05%
Return on average assets 15.52% 10.39%
Return on average equity 23.67% 15.84%
Employees 3,406 -
CDP Score - -


481 Edward H Ross Dr
ELMWOOD PARK, NJ 07407-3118
United States - Map
+1-201-7912186 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Bio-Reference Laboratories, Inc. (Bio-Reference) is a clinical testing laboratory offering testing, information and related services to physician offices, clinics, hospitals, employers and governmental units. The Company offers a list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. It primarily focuses on esoteric testing, molecular diagnostics, anatomical pathology, genetics, women�s health and correctional health care. The Company has a network of approximately 116 patient service centers located in the Northeast (primarily in New York metropolitan super-regional area) for collection of patient specimens. It conducts business in New York State counties, as well as in of New Jersey and Maryland as well as some parts of Pennsylvania, Delaware and Connecticut. In August 2013, the Company acquired most of the assets of Hunter Laboratories, located in the Bay area.

Officers and directors

Marc D. Grodman M.D. Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Sam Singer Chief Financial Officer, Senior Vice President, Chief Accounting Officer, Director
Age: 70
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Howard Dubinett Chief Operating Officer, Executive Vice President, Director
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Joseph Benincasa Independent Director
Age: 64
Bio & Compensation  - Reuters
Harry Elias Independent Director
Age: 83
Bio & Compensation  - Reuters
Gary Lederman Esq. Independent Director
Age: 79
Bio & Compensation  - Reuters
John Roglieri M.D. Independent Director
Age: 74
Bio & Compensation  - Reuters